Description
Snap-8 (also designated acetyl octapeptide-3 or acetyl glutamyl octapeptide-3) is a synthetic acetyl octapeptide originally developed as a compound in dermatological science. Structurally it is an extended analog of the better-known Argireline (acetyl hexapeptide-3), with two additional amino acids at the C-terminus.
The research mechanism lies in the modulation of the SNARE complex (Soluble NSF Attachment Receptor). The SNARE complex is central to vesicular fusion in neurotransmitter release at presynaptic membranes. Snap-8 competitively inhibits complex formation in research models and thereby reduces acetylcholine release at neuromuscular synapses. The mechanism hypothesis: through reduced cholinergic signal transmission in dermal micro-muscles, mimic movements are locally attenuated.
In research settings, Snap-8 is characterized as an alternative compound to Argireline, with a longer sequence associated in some studies with higher potency. However, the data on Snap-8 is more limited than on Argireline, which has a more extensive research history.
Snap-8 is primarily established in topical research applications. In preclinical studies, the compound is typically applied locally. Systemic bioavailability is limited, focusing research on local skin research.
Snap-8 is available in 50mg vials as 10-vial packs.
This information is for research and educational purposes only. No medical recommendations.
Risks & Safety
Snap-8 is described as well tolerated per study reports. Since the compound is primarily used topically and systemic bioavailability is limited, the profile of observable effects remains largely local.
Observed in research and user reports:
- Skin irritation: with topical use, mild redness, dryness or irritation of the application area is the most common observation.
- Limited data base: Snap-8 is considerably less well studied than the related Argireline, which has a more extensive research history.
- SNARE modulation: the mechanism rests on competitive inhibition of SNARE complex formation, and in topical research settings the effects remain confined to the treated skin area.
- No human data: robust human studies and long-term data do not exist.
This classification does not replace medical advice. Risk and responsibility for any actual use lie entirely with the buyer.
Studies
- SNARE complex modulation by synthetic peptides - Peptides 2014: Mechanism of the SNARE axis.
- Acetyl hexapeptides in dermatological research - Journal of Cosmetic Dermatology 2008: Argireline relatives as research context.
- Comparative study of anti-wrinkle peptides - Journal of Cosmetic Dermatology 2013: Comparative data on acetylated peptides.
